Welcome to GLP-1 Daily (diarioglp1.com). By using our interactive demo, browsing the website, or activating a subscription to the Patient Dashboard, you acknowledge and agree to the following terms:
1. Educational Wellness Scope & Regulatory Exemption (FDA & EU MDR)
GLP-1 Daily is an Educational Wellness, Lifestyle, and Personal Habit-Tracking Software. In strict compliance with the U.S. Food and Drug Administration (FDA) General Wellness Policy for Low Risk Devices, the European Union Medical Device Regulation (EU MDR 2017/745), and Brazilian sanitary guidelines:
- This software is NOT a medical diagnostic device, has not been evaluated or approved by the FDA or EMA, and has no autonomous therapeutic purpose.
- The system DOES NOT calculate clinical dosages, DOES NOT prescribe medications, and NEVER recommends dosage changes, titrations, or escalations. All dosing schedules are the exclusive prerogative of your licensed healthcare provider.
- The software is an adjunct personal journal intended to assist you in organizing your own records and lifestyle habits.
2. Pharmacokinetic Half-Life Simulator Clarification (t½)
Our mathematical half-life simulator employs standard first-order decay equations calibrated with published average population pharmacokinetic parameters from official FDA/EMA manufacturer package inserts (elimination half-life of approximately 168 hours for semaglutide and 120 hours for tirzepatide):
- Illustrative & Educational Function Only: The graph visualizes steady-state drug accumulation to encourage consistent adherence to weekly application days.
- Not a Serum Assay: Actual biological drug concentrations in individual blood vary widely depending on body weight, renal clearance, hepatic metabolism, and individual subcutaneous absorption rates. This model never substitutes laboratory blood tests or physician evaluations.
3. Commercial Terms, Payment Processors & FTC "Click-to-Cancel"
Subscription access to the Patient Dashboard is offered with full pricing transparency:
- Plans & Pricing: Monthly Pass ($4.90 USD international / R$ 14,90 in Brazil) or 6-Month Cycle Pass ($19.90 USD international / R$ 49,90 in Brazil). No hidden fees, setup costs, or undisclosed surcharges.
- Official Payment Processors:
- International: Processed globally with PCI-DSS Level 1 certification by Stripe Inc. (Credit/Debit Cards, Apple Pay, Google Pay).
- Web3 Crypto: Direct on-chain transfers in stablecoins (USDC and USDT) on Solana, Base, and Polygon networks with an exclusive Web3 incentive discount ($3.90/month and $15.90/6-months, saving card processing markups).
- Brazil: Processed via Asaas Gestão Financeira IP S.A. (instant PIX and domestic cards).
- Frictionless Cancellation: In accordance with the FTC Negative Option Rule, you can cancel your subscription renewal at any time with a single click inside the Stripe Customer Portal or by contacting our support team.
- 14-Day Global Satisfaction Guarantee: We offer a 14-day hassle-free money-back guarantee (satisfying EU Directive 2011/83/EU consumer rights). To request a full refund, simply message us on WhatsApp (+55 55 99968-2265) or email support@diarioglp1.com.